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The formin FMNL3 assembles plasma membrane 
protrusions that participate in cell–cell adhesion
Timothy J. Gauvin, Lorna E. Young, and Henry N. Higgs
Department of Biochemistry, Geisel School of Medicine at Dartmouth, Hanover, NH 03755
ABSTRACT FMNL3 is a vertebrate-specific formin protein previously shown to play a role in 
angiogenesis and cell migration. Here we define the cellular localization of endogenous 
FMNL3, the dynamics of GFP-tagged FMNL3 during cell migration, and the effects of FMNL3 
suppression in mammalian culture cells. The majority of FMNL3 localizes in a punctate pat-
tern, with >95% of these puncta being indistinguishable from the plasma membrane by fluo-
rescence microscopy. A small number of dynamic cytoplasmic FMNL3 patches also exist, 
which enrich near cell–cell contact sites and fuse with the plasma membrane at these sites. 
These cytoplasmic puncta appear to be part of larger membranes of endocytic origin. On the 
plasma membrane, FMNL3 enriches particularly in filopodia and membrane ruffles and at 
nascent cell–cell adhesions. FMNL3-containing filopodia occur both at the cell–substratum 
interface and at cell–cell contacts, with the latter being 10-fold more stable. FMNL3 suppres-
sion by siRNA has two major effects: decrease in filopodia and compromised cell–cell adhe-
sion in cells migrating as a sheet. Overall our results suggest that FMNL3 functions in assem-
bly of actin-based protrusions that are specialized for cell–cell adhesion.
INTRODUCTION
Formins are actin polymerization factors, and the large number of 
mammalian formins (15 distinct genes) suggests a wide range of 
cellular functions (Higgs and Peterson, 2005; Campellone and 
Welch, 2010). However, precise cellular function is poorly under-
stood for many mammalian formins, as opposed to our much better 
understanding of formin function in budding or fission yeast 
(Moseley and Goode, 2006; Kovar et al., 2011). Part of the chal-
lenge to elucidation of mammalian formin function is the diversity of 
mammalian actin-based structures, which are often spatially and 
structurally interrelated.
The FMNL subfamily of formins (also called FRL formins; Higgs 
and Peterson, 2005) is metazoan specific, not being found in yeasts 
or plants. Whereas Drosophila and Caenorhabditis elegans contain 
one FMNL, vertebrates contain three genes: FMNL1, FMNL2, and 
FMNL3. Each vertebrate FMNL possesses at least two splice vari-
ants. As with other formins, FMNLs are modular (Vaillant et al., 2008; 
Heimsath and Higgs, 2012), with the following functional regions 
(Figure 1): GTPase-binding domain (GBD), diaphanous inhibitory 
domain (DID), dimerization domain (DD), formin homology 1 do-
main (FH1), formin homology 2 domain (FH2), WH2-like domain 
(WH2L), and diaphanous autoregulatory domain (DAD). The FH2 
domain binds actin- filament barbed ends and can accelerate fila-
ment nucleation, as well as regulate filament elongation. In FMNLs, 
the FH2 has poor actin nucleation activity but can bundle filaments 
in vitro (Vaillant et al., 2008; Harris et al., 2004, 2010; Block et al., 
2012). C-terminal to the FH2 domain, FMNLs contain a WH2-like 
actin monomer–binding sequence, which is capable of capping 
barbed ends in isolation or accelerating actin nucleation when cou-
pled to the FH2 domain (Heimsath and Higgs, 2012). Similar to 
other formins, FMNL regulation is through autoinhibitory interaction 
of the DID and DAD regions, with activation by Rho GTPase binding 
to the GBD (Seth et al., 2006; Block et al., 2012). Finally, FMNLs are 
known or suspected to be N-terminally myristoylated (Han et al., 
2009; Block et al., 2012; Moriya et al., 2012), which is a modification 
not found in other formins.
The cellular functions of FMNLs are incompletely understood. 
FMNL1 (also called FRL1) has been implicated in diverse functions, 
including cell migration, phagocytosis, myofibril development, podo-
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background (see later discussion of Figure 
7D and Supplemental Figure S6B). We focus 
on the peri pheral, siRNA-sensitive stained 
regions.
FMNL3 mostly appears as punctate stain-
ing, with puncta diameters close to the limit 
of resolution (370 ± 50 nm, n = 82; Figure 
2D). In cells plated on glass overnight, these 
puncta are present throughout the cell but 
enrich at areas of apparent membrane pro-
trusion (Figure 2A and Supplemental Figure 
S1A). This enrichment is observed most eas-
ily when cells are induced to spread upon 
replating. U2OS cells spread asymmetrically 
on laminin, allowing clear observation of the 
FMNL3-rich spreading edge as opposed to 
the FMNL3-poor nonspreading edge (Figure 
2B). In addition, short filopodia are visible at 
the spreading edges of U2OS cells on lami-
nin, and FMNL3 is enriched at filopodial tips in these cells (Figure 2B, 
inset). 3T3 cells plated on poly-l-lysine (PLL) spread uniformly, and 
FMNL3 enriches significantly at the spreading edge, still in a punc-
tate pattern (Supplemental Figure S1B).
We also examined FMNL3 localization in a wound-healing con-
text in which cells are plated on glass at high density overnight and 
then scrape-wounded and allowed to migrate into the wound for 
several hours. Again, FMNL3 enriches at the leading edge during 
wound closure (Figure 2C and Supplemental Figure S1C), but 
filopodia are not apparent upon fixation in either 3T3 or U2OS cells 
(however, see later discussion of evidence that fixation ablates these 
filopodia, Figure 8). FMNL3 also enriches at some but not all areas 
of cell–cell contact (Figure 2C and Supplemental Figure S1C). From 
these results, we conclude that FMNL3 localizes largely to diffrac-
tion-limited puncta throughout the cell, with particular enrichment 
at areas of active cell protrusion or cell–cell contacts.
We further investigated FMNL3 enrichment to actively protruding 
regions of the plasma membrane using serum readdition after serum 
starvation of NIH 3T3 cells. The most intense FMNL3 enrichment is to 
areas of cell–cell contact, with clear enrichment within 10 min (Figure 
3). N-cadherin, the predominant cadherin in 3T3 cells, enriches at 
contact sites on a similar time scale (Figure 3). At early time points 
after serum readdition, the FMNL3/N-cadherin enrichment resem-
bles interdigitating filopodia, similar to observations made in other 
systems (Adams et al., 1998; Vasioukhin et al., 2000; Brevier et al., 
2008; Hoelzle and Svitkina, 2012). Later in the process, the contact 
site becomes compact, and the filopodia are no longer evident.
Live-cell analysis of FMNL3 localization and dynamics
The preceding experiments were conducted using immunofluores-
cence detection of endogenous FMNL3. To analyze FMNL3 dynam-
ics, we developed a green fluorescent protein (GFP)–fusion protein. It 
is worth mentioning that several challenges presented themselves 
during this development. First, there are two known alternatively 
spliced sites for FMNL3: a variably present 51–amino acid insert in the 
DID, and alternate C-termini of 30 or 29 amino acids (Figure 1). We 
determined that U2OS cells expressed the variant containing the DID 
insert and the NC C-terminus (Supplemental Figure S2) and used this 
variant (called “NC”) henceforth. Second, we found that placing the 
GFP at either the N- or C-terminus caused localization patterns that 
were clearly different from that of endogenous FMNL3, with GFP-
FMNL3 localization being entirely internal and FMNL3-GFP being 
entirely on the plasma membrane and causing a significant increase 
Gomez et al., 2007; Mersich et al., 2010; Favaro et al., 2013; Naj et al., 
2013; Rosado et al., 2014). One FMNL1 splice variant localizes at or 
near the Golgi and plays a role in Golgi structure and function (Colon-
Franco et al., 2011). FMNL2 (also called FRL3) plays a role in cell mi-
gration (Block et al., 2012) and appears to be particularly important in 
metastasis of certain cancers (Zhu et al., 2008, 2011; Kitzing et al., 
2010; Li et al., 2010; Liang et al., 2013). In mouse melanoma cells, 
FMNL2 localizes to the leading-edge plasma membrane, where it ap-
pears to promote lamellipodial extension by allowing elongation of 
Arp2/3 complex–nucleated filaments (Block et al., 2012).
The cellular functions of FMNL3 (also called FRL2) are less de-
fined than those of FMNL1 or FMNL2. FMNL3 plays a role in angio-
genesis in zebrafish (Hetheridge et al., 2012). In PC3 prostate cancer 
cells, which migrate as single cells, FMNL3 depletion inhibits cell 
migration (Bai et al., 2011; Vega et al., 2011). However, there is little 
information on what types of actin-based structure are promoted by 
FMNL3 (filopodia, lamellipodia, etc) and no information as to 
FMNL3’s localization. A previous study in our laboratory showed 
that overexpression of minimal FMNL3 constructs (containing FH1 
and FH2 domains) potently induced filopodia, whereas a similar 
construct of FMNL1 did not (Harris et al., 2010), but this result does 
not speak to the function of the endogenous protein.
In this work, we examine the location, dynamics, and function of 
FMNL3 in adherent culture cells (U2OS and 3T3). We show that the 
majority of FMNL3 localizes in a punctate pattern at the plasma 
membrane, with particular enrichment at filopodia, ruffles, and cell–
cell adhesions. A small pool of intracellular FMNL3 is present as 
dynamic puncta that enrich near cell–cell adhesion sites and are as-
sociated with larger internal membrane structures. FMNL3 suppres-
sion decreases both filopodial number and stability at the leading 
edge, as well as the integrity of cell–cell contacts.
RESULTS
FMNL3 localizes in a punctate pattern that enriches at the 
leading edge and cell–cell contacts
As a first step in determining FMNL3 function, we examined localiza-
tion of the endogenous protein in U2OS human osteosarcoma cells 
(Figure 2) and NIH 3T3 mouse fibroblasts (Supplemental Figure S1) by 
immunofluorescence microscopy, using an affinity-purified antibody 
against the FH2 domain. The specificity of this antibody for FMNL3 is 
indicated by the effect of small interfering RNA (siRNA) suppression, 
which removes all of the peripheral immunofluorescence staining, 
leaving a hazy perinuclear staining that we interpret as nonspecific 
FIGURE 1: FMNL3 domain map and splice variants. DAD, diaphanous autoregulatory domain. 
DID, diaphanous inhibitory domain; DD, dimerization domain; FH1, formin homology 1 domain; 
FH2, formin homology 2 domain; GBD, GTPase-binding domain; WH2L, WH2-like domain. 
Numbers indicate amino acid positions. Splice variants: DID insert (153–203) and alternate 
C-termini (NC and PH variants, named by the two C-terminal residues). Red letters represent the 
last common sequence before the alternative splice site. DAD is predicted to extend into the 
alternately spliced region (with L1000 predicted to make an important interaction with DID).
Volume 26 February 1, 2015 FMNL3 cellular dynamics | 469 
Using this cell line, we first examined localization of FMNL3 
puncta in more detail. Our initial laser-scanning confocal microscopy 
analysis of fixed cells stained for endogenous FMNL3 suggested that 
FMNL3 puncta were predominately at/near the plasma membrane 
(PM; Figure 4A), but the flattening that occurred upon cell fixation/
permeabilization rendered interpretation of these data challenging. 
Similar three-dimensional (3D) reconstructions of live U2OS cells ex-
pressing FMNL3-NC-GFPint provide a much less ambiguous result. 
As a marker for both the plasma membrane and internal membranes, 
we used fluorescent wheat germ agglutinin (WGA), which binds N-
acetyl-glucosamine and sialic acid moieties on the cell surface and 
gets rapidly endocytosed (Raub et al., 1990). Immediately after WGA 
treatment, the vast majority of FMNL3 puncta reside at positions in-
distinguishable from the PM (Figure 4B and Supplemental Movies S1 
in filopodia (Supplemental Figure S3). For this reason, we developed 
a construct in which the GFP was placed at the N-terminal end of the 
FH1 domain (construct called the FMNL3-NC-GFPint), which is a re-
gion predicted to adopt a nonfolded structure (Paul and Pollard, 
2009; Courtemanche and Pollard, 2012). FMNL3-NC-GFPint pro-
duces a pattern more similar to endogenous FMNL3 in fixed cells, 
both at leading edge and puncta (Supplemental Figure S3). Third, we 
were unable to generate stable cell lines constitutively expressing 
FMNL3-NC-GFPint from a cytomegalovirus promoter. For this reason, 
we developed a stable doxycycline-inducible FMNL3-NC-GFPint line 
in U2OS cells, which displays low-level expression after 18–24 h of 
induction. Quantification of GFP-FMNL3 and total FMNL3 levels sug-
gests that FMNL3-NC-GFPint levels are significantly less than endog-
enous FMNL3 levels in all cells examined (Supplemental Figure S4).
FIGURE 2: Localization of FMNL3 in U2OS cells. U2OS cells were examined in three conditions: (A) plated on glass 
coverslips overnight, (B) plated on laminin coated slips for 120 min, and (C) during wound-healing assay, 23 h after 
wounding. Stains are anti-FMNL3 antibody (green), phalloidin for actin filaments (red), and DAPI for DNA (blue). Right, 
zooms. Arrow in B indicates a filopodium, and arrow in C indicates region of cell–cell contact, which runs diagonally 
from this arrow to the lower right corner. Scale bars,10 μm (full images), 5 μm (zooms). (D) Histogram of FMNL3 puncta 
diameters from images of fixed U2OS cells stained with anti-FMNL3 antibodies. Bins are 50 nm, bars are centered at the 
maximum value of that bin (e.g., bar centered on 350 nm represents 300–350 nm). Similar to images for NIH 3T3 cells 
shown in Supplemental Figure S1.
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and S2), with <5% of the puncta being clearly separate from the PM 
(three cells counted, 14/280, 17/476, and 17/586 internal puncta/
total puncta, respectively). As opposed to the spherical structures 
observed by fixed-cell immunofluorescence, the surface FMNL3 
staining observed in 3D reconstruction images of FMNL3-NC-GFPint 
is more oblate and somewhat interconnected.
The cytoplasmic FMNL3 puncta are rapidly motile in the vicinity 
of the FMNL3-enriched cell–cell contact, with some undergoing 
random movement and others moving directionally (Figure 5, A and 
B, and Supplemental Movie S3). Occasionally, the puncta move to 
and fuse with the plasma membrane (Supplemental Movie S2). We 
observe no LifeAct enrichment around these puncta (unpublished 
data), suggesting that their dynamics is actin-independent. When 
cells are treated with WGA for longer times to label endocytic com-
partments, subpopulations of cytoplasmic FMNL3 and WGA struc-
tures colocalize in an intriguing manner. The cytoplasmic FMNL3 
puncta appear as diffraction-limited spheres that are clearly associ-
ated with the larger WGA-labeled structures (Figure 5, C and D). 
Both the FMNL3 and associated WGA structures can move rapidly 
in the cytoplasm (Figure 5D and Supplemental Movie S4).
Next we examined the dynamics of FMNL3-NC-GFPint at the 
cell surface. On the basal surface, FMNL3 puncta are relatively static, 
showing little change in movement over several minutes (Figure 
6A). The apical puncta are difficult to track because of the rapid 
changes in the surface in general. Near protrusive regions, however, 
FMNL3 displays an association with membrane ruffles that are also 
enriched in actin, as detected by LifeAct (Figure 6B and Supplemen-
tal Movie S5) or mCherry-actin (Supplemental Figure S5). These 
ruffles are highly dynamic but do not move consistently in a retro-
grade manner (Figure 6C and Supplemental Movie S5). The ruffles 
also stain brightly with WGA, and the dynamics of the WGA stain 
overlaps the dynamics of FMNL3 in the ruffles (Figure 6, B and C). 
Treatment with latrunculin B causes dissipation of both FMNL3 and 
actin signals within 2 min (Supplemental Figure S5).
FIGURE 4: Localization of FMNL3 puncta. (A) XZ-projection of fixed 
U2OS cells immunostained for endogenous FMNL3 (green), plasma 
membrane (red), and DNA (blue), then imaged by laser scanning 
confocal microscopy using 100-nm Z-slices. Plasma membrane labeled 
with FM4-64 (50 μM in Hank’s buffered salt solution) for 1 min before 
fixation. XZ-projection reconstructed using Nikon Elements software 
with 2× scale of Z-axis. Scale bar, 10 μm (XY), 5 μm (Z). (B) A 3D 
FIGURE 3: FMNL3 translocates to nascent cell–cell junctions upon serum addition. Serum-starved NIH 3T3 cells were 
treated with serum-containing medium (10% newborn calf serum) for the indicated times and then fixed and stained for 
FMNL3 (green), N-cadherin (red), and DNA (blue). Scale bar, 10 μm (close-ups, 5 μm ).
reconstruction of FMNL3-NC-GFPint (green) and Alexa 647–labeled 
WGA (red) in live U2OS cell at <1 min after WGA treatment (top) and 
at 5 min after treatment (bottom). The Z-stack was deconvolved 
before assembling the 3D image. Scale bar, 2 μm (XY), 1 μm (Z). See 
corresponding Supplemental Movies S1 and S2.
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ability to attain >85% suppression levels (Figure 7, A and B). FMNL3 
suppression also reduces by >80% the number of puncta observed 
using the anti-FMNL3 antibody (Figure 7, C and D), suggesting that 
these puncta do indeed correspond to FMNL3. A similar reduction 
in anti-FMNL3–stained puncta occurs upon FMNL3 suppression in 
3T3 cells (Supplemental Figure S6).
FMNL3 suppression does not have a strong effect on spreading 
rate for U2OS on laminin or 3T3 cells on PLL (unpublished data), nor 
does FMNL3 suppression affect wound closure rate in the wound-
healing assay (Supplemental Figure S7, A and B). However, FMNL3 
suppression does compromise filopodial abundance during both 
spreading and wound healing. In U2OS cells spreading on laminin, 
filopodial density decreases by >50% upon FMNL3 suppression 
(Figure 7, E and F). In live-cell analysis of wound healing, we detect 
abundant and highly dynamic filopodia at the leading edges of con-
trol wound-edge cells, with lifetimes of 116 ± 56 s (Figure 8A and 
Supplemental Movie S8). FMNL3 suppression causes a 3.4-fold 
reduction in filopodial number and a significant decrease in the 
FMNL3 also enriches in filopodia, both at protrusive edges and 
at cell–cell contacts (Figure 6D). The stability of filopodia at these 
two locations differs greatly, with protrusive-edge filopodia having 
much shorter lifetimes (median 2.5 ± 1.7 min) than cell-cell–contact 
filopodia (median 25 ± 6.5 min), with many contact filopodia being 
stable throughout the 27-min viewing period (Figure 6, D and E, and 
Supplemental Movies S6 and S7). The cell–cell contact protrusions 
appear to be bona fide filopodia and not retraction fibers because 
the majority exhibits clear growth during observation time and are 
not under any apparent tension (Supplemental Movie S7). We note 
that the FMNL3 features observed here (surface puncta, cytoplas-
mic puncta, ruffles, and filopodia) are not dependent on WGA treat-
ment (unpublished data).
FMNL3 suppression results in loss of leading-edge filopodia 
and unstable cell–cell contacts
We used siRNA-mediated suppression to examine the importance 
of FMNL3 to cellular dynamics, focusing on U2OS cells due to the 
FIGURE 5: Dynamics of cytoplasmic FMNL3 puncta near cell–cell contact sites. (A) Individual time points from 
Supplemental Movie S2, following cytoplasmic FMNL3-NC-GFPint puncta near the cell–cell contact. Note the circled 
punctum, which has recently undergone fission from the larger punctum and fuses with the plasma membrane (arrow). 
Scale bar, 5 μm. See corresponding Supplemental Movie S3. (B) Trajectory plots for individual intracellular puncta, with 
the origin representing the starting position for each punctum. Units are in pixels, 0.151 μm/pixel. (C) Single time frame 
(14 min) from live-cell recording, showing FMNL3-NC-GFPint (green) and Alexa 647–WGA (red) after >10 min of WGA 
treatment, which allows time for endocytic uptake of WGA. Individual FMNL3 (left) and WGA (center) are also shown 
in black and white. Box indicates approximate region shown in D and Supplemental Movie S4. Scale bar, 5 μm. 
(D) Montage taken from Supplemental Movie S4, showing FMNL3-NC-GFPint (green) and WGA (red) dynamics over 
50-s period (individual frames represent 10-s intervals). Two WGA-containing particles are labeled. Particle 1 is relatively 
static over this time period, whereas particle 2 moves rapidly, becoming dimmer but still distinguishable during the 
process. See also Supplemental Movie S4 from 14:10 to 15:00. Scale bar, 2 μm.
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DISCUSSION
In this article, we show that FMNL3 localizes in a punctate pattern 
in U2OS and 3T3 cells, with >95% of these puncta being at or near 
the plasma membrane. Further enrichment occurs in several 
places: at the leading-edge plasma membrane, particularly at 
filopodial tips; at the ridges of apical membrane ruffles; and at 
cell–cell contact sites. The relatively infrequent cytoplasmic 
FMNL3 puncta are dynamic and can fuse with the plasma mem-
brane at cell–cell contact sites. Suppression of FMNL3 by siRNA 
causes a reduction in filopodia at the leading edge and in cell–cell 
adhesion for U2OS cells migrating as a sheet in wound-healing 
assays.
The identity of the abundant FMNL3 puncta found at the cell 
surface is intriguing. From 3D reconstructions of cells expressing the 
GFP-FMNL3 construct, we find 300–600 surface puncta, all at or 
near the diffraction limit. At the level of light microscopy, we cannot 
determine whether these puncta represent vesicles that are closely 
associated with the plasma membrane (akin to secretory vesicles) 
or are actually regions of FMNL3 enrichment on the plasma 
lifetimes of the remaining filopodia (70.6 ± 37 s; Figure 8, A–C, and 
Supplemental Movie S9). The presence of leading-edge filopodia in 
our live-cell imaging of wound healing contrasts with our finding of 
few filopodia in fixed cells under the same conditions (Figure 2C), 
suggesting that formaldehyde fixation destroys these transient 
structures.
Because FMNL3 enriches at cell–cell contacts, we analyzed the 
effects of FMNL3 suppression on the stability of cell–cell contacts 
during wound healing. Control U2OS cells migrate as a sheet, with 
few gaps between cells (Figure 9A). In fixed-cell assays, the area of 
these gaps increases >2.5-fold upon FMNL3 suppression (Figure 
9B). In live-cell imaging, control cells maintain tight contact, and any 
small gaps close rapidly (Figure 9C and Supplemental Movie S10). 
In contrast, FMNL3-suppressed cells display frequent gaps between 
cells, and these gaps close approximately threefold more slowly 
(Figure 9, C and D, and Supplemental Movie S11). Gaps appear to 
result from the reduced ability of neighboring cells to maintain sta-
ble interaction upon contact, suggesting that FMNL3 suppression 
results in decreased cell–cell adhesion.
FIGURE 6: Dynamics of FMNL3 in basal puncta, membrane ruffles, and filopodia. All images use U2OS cells expressing 
FMNL3-NC-GFPint. (A) Three frames of a time-lapse movie examining FMNL3 on the basal surface, with the overlay of 
the three frames on the right. In the overlay, note the preponderance of white puncta, indicating that they did not 
displace significantly over the 4-min viewing time. Scale bar, 5 μm. (B) 3D reconstructions of protrusive regions, with 
FMNL3 in green and either LifeAct (left) or WGA (right) in red. Ruffles protrude above the apical cell surface. 
(C) Individual frames from time-lapse movies, tracking FMNL3 and either LifeAct (top) or WGA (bottom). Scale bar, 5 μm. 
Corresponds to Supplemental Movie S5 (LifeAct). (D) Individual frames from time-lapse movies following FMNL3 in 
filopodia at a free cell edge (“edge,” top) or a cell edge that is in contact with another cell (“contact,” bottom). In the 
latter case, the cell being contacted is not expressing FMNL3 (and is invisible here but visible by DIC microscopy). Scale 
bar, 5 μm. Corresponds to Supplemental Movies S6 and S7. (E) Filopodia lifetimes for contact and edge filopodia, 
measured from five cells. A substantial proportion of contact filopodia were present for the entire recorded time (27 min).
Volume 26 February 1, 2015 FMNL3 cellular dynamics | 473 
be components of dynamic internal membranes that are deliver-
ing components to the contact site. There is ample evidence for 
recycling of adhesion components at cell–cell contact sites (Le 
et al., 1999; Akhtar and Hotchin, 2001; Palacios et al., 2005; 
Desclozeaux et al., 2008; Peglion et al., 2014), and FMNL3 could 
be either part of this recycling system or one of the components 
that is recycled. The discrete enrichment of FMNL3 puncta to 
specific regions of these internal membranes is intriguing 
and could suggest confinement on associated small vesicles or 
membrane, representing lateral segregation (“domains”). Either 
possibility is intriguing functionally.
The relatively sparse cytoplasmic FMNL3 puncta display inter-
esting features. First, they enrich near cell–cell contact sites, as 
opposed to a noncontacting region of the cell. Second, they are 
dynamic and can translocate to the cell–cell contact site, where 
they fuse with the plasma membrane. Third, the puncta are as-
sociated with larger membrane structures derived from endocy-
tosis. These features suggest that the cytoplasmic puncta might 
FIGURE 7: Effects of FMNL3 suppression in U2OS cells. (A) Western blot showing suppression of FMNL3 using two 
different siRNAs. (B) Percentage suppression, determined by density measurements from Western blots. 
(C) Quantification of average puncta per 10 μm2 area in control and FMNL3-depleted cells. Error bars represent SD. 
(D) Cells plated on laminin-coated coverslips for 90 min for control (top) and siRNA1 treatment (bottom). Stains were for 
FMNL3 (green), actin filaments (red), and DNA (blue). Scale bar, 10 μm. (E) Close-ups of spreading edge in control (left) 
siRNA knockdown (right column) shows decrease of filopodia present along the edge compared with control (left 
column). Filopodia indicated with arrows. Scale bar, 5 μm. (F) Graph quantifying filopodia density as filopodia per 10-μm 
length along the spreading edge. Error bars indicate SD; p < 0.001.
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greater interest, C-terminally tagged FMNL3 appeared “constitu-
tively active,” localizing intensely to the plasma membrane and 
causing a significant increase in filopodia. This result suggests that 
the extreme C-terminus influences FMNL3 regulation and might re-
late to previous findings showing FMNL3 to be less tightly regulated 
than FMNL2 (Vaillant et al., 2008) and mDia2 (Harris et al., 2010).
It is interesting that our study finds no defect in cell migration 
upon FMNL3 suppression, whereas a previous study did identify a 
migration defect (Bai et al., 2011). A major difference in the two 
studies is the cell lines used. In our study, we used U2OS and 3T3 
cells, both of which display strong cell–cell adhesion and migrate 
as a sheet in wound-healing assays. The previous study used PC3 
human prostate cancer cells, which display weak cell–cell adhesion 
and migrate as single cells in wound-healing assays. One possibil-
ity is that FMNL3’s role is cell-type dependent, participating pre-
dominantly in cell–cell adhesion in adhesive cell lines and partici-
pating more in cell migration in less adhesive cells. In any case, it 
is clear that FMNL3, like the other vertebrate FMNLs, has several 
cellular roles, so the elucidation of these roles is likely to produce 
new surprises in the future.
MATERIALS AND METHODS
Cell lines and culture conditions
U2OS (human osteosarcoma, originally from Duane Compton, 
Dartmouth, Hanover, NH) and NIH 3T3 cells (originally from 
possibly membrane segregation on the endosomal membrane 
(Trajkovic et al., 2008).
The finding that FMNL3 enriches in filopodia, as well as the effect 
of FMNL3 suppression on filopodial abundance, extends our previ-
ous observation that minimal constructs of FMNL3 (containing the 
FH1 and FH2 domains) are capable of filopodial induction (Harris et al., 
2010). Our work here shows that filopodial assembly is a bona fide 
function of FMNL3, as opposed to a potentially artifactual effect of 
the FH1-FH2 construct. FMNL3-assembled filopodia might be spe-
cialized for cell–cell adhesion, based on two observations: the filopo-
dia are 10-fold more stable when in contact with another cell, and 
FMNL3 suppression causes defects in cell–cell adhesion. Filopodia 
clearly play a role in cadherin-mediated cell–cell adhesion in both 
epithelial (Adams et al., 1998; Vasioukhin et al., 2000; Brevier et al., 
2008) and endothelial cells (Hoelzle and Svitkina, 2012), and our 
work here shows that N-cadherin enriches with FMNL3 at cell–cell 
contacts. It will be interesting to determine whether FMNL3-induced 
filopodia preferentially enrich cell–cell adhesion molecules.
The difficulty experienced in producing a GFP-tagged FMNL3 
construct that suitably mimics endogenous FMNL3 localization 
might be an indication of peculiarities in FMNL3 regulation. N-ter-
minally tagged FMNL3 did not localize to the plasma membrane 
but instead to intracellular aggregates, which might not be surpris-
ing, given the N-terminal myristoylation site that was ablated by the 
tag (Han et al., 2009; Block et al., 2012; Moriya et al., 2012). Of 
FIGURE 8: FMNL3 suppression reduces filopodial number and lifetime at leading edge of U2OS cells in wound-healing 
assays. (A) Time-lapse montage of DIC images of leading edge of cells in control and knockdown cells. Arrows indicate 
filopodia. Scale bar, 10 μm. Corresponds to Supplemental Movies S8 and S9. (B) Quantification of average filopodium 
lifetime. Error bars indicate SD. (C) Quantification of filopodia assembly frequency. Error bars indicate SD.
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using primers containing Kpn1 and EcoR1 sites, and ligated with 
the rest of the FMNL3 ORF into the pcDNA3.1 vector (Invitrogen, 
Waltham, MA). All enhanced GFP constructs used were the A206K 
mutant (low dimerization affinity; Zacharias et al., 2002). The 
FMNL3-GFP and GFP-FMNL3 constructs were in the pEGFP-N1 
and pEGFP-C1 vectors, respectively (Clontech). The FMNL3-NC-
GFPint construct was made in the pcDNA3.1 vector by digesting 
with Bsu36i and inserting an amplified GFP construct containing 
a flexible GSG linker and Bsu36i sites on both ends. The GFP 
construct is inserted at amino acids 512–513 in the FMNL3 se-
quence (Supplemental Figure S4). The FMNL3-NC GFPint was 
moved from pcDNA3.1 to pTRE-tight (Clontech) for Tet-on sys-
tem using EcoR1/NotI restriction sites. FMNL3-GFP was cloned in 
the pGFP-N1 vector with BamH1 sites, and the GFP-FMNL3 con-
struct was cloned into GFP-C1 vector using BamH1 sites. siRNA 
constructs were purchased from Life Technologies (Carlsbad, CA) 
Gregg Gundersen, Columbia University, New York) were cultured in 
DMEM (Corning, Corning, NY) and 10% newborn calf serum 
(Altanta Biologicals, Flowery Branch, GA) at 37°C and 5% CO2. For 
U2OS cell lines transfected with the pTet-on Advance plasmid 
(Clontech, Mountain View, CA) and U2OS Tet-on FMNL3-NC-
GFPint construct, the serum used was 10% Tet-approved fetal 
bovine serum (Clontech). To induce expression of FMNL3-NC 
GFPint, cells were incubated in 1 μg/ml doxy cycline (Fisher Scientific, 
Pittsburgh, PA) for 18–24 h before imaging.
Plasmids and siRNA constructs
All FMNL3 constructs were created from a human FMNL3 open 
reading frame (ORF) containing the DID insert and the PH C-ter-
minal splice variant (Figure 1), a kind gift from John Copeland 
(University of Ottawa, Canada). To generate the NC variant, the 
NC C-terminus was amplified by 23°C PCR from U2OS cell cDNA, 
FIGURE 9: FMNL3 suppression increases intercellular gaps between U2OS cells in wound- healing assays. (A) Phase-
contrast (top) and merged fluorescence images (bottom) of FMNL3 (green), actin (red), and DNA (blue) along wound 
edge of control (left) and siRNA1-treated cells (right) show an increase of intercellular gaps (marked by asterisks) upon 
FMNL3 depletion. Scale bars, 10 μm. Corresponds to Supplemental Movies S10 and S11. (B) Graph shows average 
areas of intercellular spaces. Error bars show SEM; p < 0.005. (C) DIC time-lapse montage of wound edge in control and 
knockdown cells. Arrows indicate intercellular gaps forming during time lapse. Scale bar indicates 10 μm. (D) Average 
lifetime of intercellular gaps during wound healing. Error bars indicate SD.
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assessed for formation of a complete monolayer before making 
scratches. Scratches were made by attaching a p10 tip to a vacuum 
manifold set at half strength; a straight line was drawn down 
the center of the coverslip by holding the tip perpendicular to the 
coverslip. Wound width was measured at three different spots 
along the wound from images taken with the 4× objective. For live 
imaging, cells were incubated for 2 h after making scratches be-
fore imaging.
Live-cell microscopy
Coverslips were mounted into modified Rose chambers and then 
onto a Wave FX spinning disk confocal microscope (Quorum 
Technologies [Guelph, Canada], on a Nikon Eclipse microscope) 
with Bionomic Controller (20/20 Technology) temperature-con-
trolled stage set to 37°C. After equilibrating to temperature for 
5 min, cells were imaged through the 60×/1.4 NA Plan Apo objec-
tive (Nikon USA, Melville, NY) using the 491-nm laser and 525/20 
filter for GFP and the 561-nm laser and 593/40 filter for mono-
meric red fluorescent protein and 655/90 for far red and differen-
tial interference contrast (DIC). Z-stacks of 0.2 μm were collected 
for each color at 10- to 30-s intervals. Maximum intensity projec-
tions from five Z-slices were assembled using Nikon Elements 
software. For 3D reconstructions of Z-stacks of fixed cells, images 
were deconvolved using Huygens software and reassembled us-
ing Nikon Elements. Alexa 647–labeled WGA was resuspended in 
dimethyl sulfoxide (DMSO) at a concentration of 1 mg/ml, diluted 
to 500 ng/ml in medium, and added to cells, which were imaged 
within 1 min to capture the plasma membrane. To observe endo-
cytic compartments, cells were imaged 5–10 min after WGA treat-
ment (endocytic structures were visible within 3 min of treatment). 
FM4-64 was resuspended fresh from a 50-μg vial in DMSO. The 
dye was then diluted to 50 μM Hank’s balanced salt solution and 
added to cells on ice for 1 min before fixation.
Quantification
Intercellular area was defined as the total area between two cells 
along their lateral contact (perpendicular to the wound direction) 
at the edge or first interior layer of a wounded monolayer. The 
lateral contact length varied between 30 and 60 μm for both con-
trol and FMNL3-suppressed cells. Filopodia frequency was calcu-
lated from the number of filopodia that appeared in 25 min along 
a 50-μm length of protrusive cell edge, and filopodia lifetime was 
determined from frame-by-frame analysis of the movie files. For 
filopodia at cell–cell contacts, many lasted the length of the movie 
(∼25 min) and thus were given that lifetime. Puncta diameter was 
measured using Nikon Elements software from 100×/1.4 NA im-
ages of fixed cells stained with anti-FMNL3. Because the puncta 
appeared circular by eye, the diameter was measured horizontally 
across each punctum. From this analysis, the mean punctual diam-
eter is 370 ± 50 nm (n = 82), with no observed punctum being 
>540 in nm diameter. To quantify the expression level of FMNL3-
NC-GFPint, we examined fixed cells by immunofluorescence mi-
croscopy, staining induced and uninduced cells with anti-FMNL3 
and Alexa 546–labeled secondary antibody. Anti-FMNL3 recog-
nizes both endogenous FMNL3 and FMNL3-NC-GFPint. We quan-
tified total GFP and Alexa 546 fluorescence for each cell (normal-
izing both to cell area, and background subtracting from areas of 
the coverslip devoid of cells) and plotted total FMNL3 fluores-
cence (Alexa 546) as a function of GFP fluorescence. The resulting 
graph is shown in Supplemental Figure S4 and indicates that even 
the cells with highest FMNL3-NC-GFPint induction had no more 
than twofold increase in total FMNL3. The cells selected for 
(siRNA1, CAUUCGUUCUUACAAGGAA; siRNA 2, GCAUCAAGG-
AGACAUAUGA). Scrambled siRNA was purchased from Inte-
grated DNA Technologies (Negative Control #1).
For production of the stable FMNL3-NC-GFPint cell line, U2OS 
stably expressing pTet-on Advance (gift from Bernardo Orr 
[Dartmouth] and Duane Compton) were transfected with FMNL3-
NC GFPint in the pTRE-tight vector (Clontech) using jetPrime 
(Polypus Transfection). Cells were selected using 0.2 mg/ml G418 in 
growth medium. Cells were then selected using 0.1 mg/ml hygro-
mycin (Clontech) for 2 wk (to reselect for the pTRE-tight vector) be-
fore picking colonies. After selection, colonies were picked, and cells 
expressing FMNL3-NC-GFPint were screened by anti-FMNL3 West-
ern blotting after inducing each colony with 1 μg/ml doxycycline for 
24 h. Pilot experiments showed undetectable expression in the ab-
sence of doxycycline (Supplemental Figure S4) and that expression 
levels were relatively constant from 18 to 30 h postinduction.
Antibodies and other labeling reagents
The anti-FMNL3 antibody was raised in guinea pig (Covance) using 
the FMNL3-FH1FH2 construct (Harris et al., 2010) as antigen and 
affinity-purified using this same antigen coupled to sulfolink resin 
(Thermo Scientific, Waltham, MA). Anti–N-cadherin (mouse, #C3845) 
and anti-tubulin (mouse, DM1alpha) antibodies were purchased from 
Sigma-Aldrich (St. Louis, MO). Alexa 488 and Alexa 546–labeled 
anti–guinea pig secondary antibody and FM4-64 were purchased 
from Life Technologies. Texas Red–labeled anti-mouse was obtained 
from Vector Laboratories. Tetramethylrhodamine isothiocyanate 
(TRITC)–labeled phalloidin was purchased from Sigma-Aldrich. Alexa 
647–WGA (Life Technologies) was a kind gift from Brent Berwin 
(Geisel School of Medicine at Dartmouth).
Cell treatments, fixation, and staining for 
immunofluorescence
For the spreading assay, 12-mm coverslips were coated overnight 
with either 0.01% PLL (Sigma-Aldrich) or 20 μg/μl laminin (Sigma-
Aldrich). A confluent plate of cells was trypsinized and diluted in 
phosphate-buffered saline (PBS) before two washes in PBS. Cells 
were resuspended to 100,000 cells/ml in prewarmed medium before 
plating 0.5 ml onto coated coverslips. Cells were incubated at 37°C 
until ready to fix. For serum readdition, NIH 3T3 cells were serum 
starved by rinsing twice with PBS and incubating in DMEM for at least 
20 h. Medium was changed to normal growth medium (10% new-
born calf serum) for indicated times before fixation. After treatment, 
cells were washed once with room temperature PBS, then immedi-
ately fixed with 4% paraformaldehyde (Electron Microscopy Sciences, 
Hatfield, PA) diluted in room temperature PBS for 20 min. Cells were 
washed and permeabilized with 0.20% Triton X-100 for 20 min at 
room temperature. Cells were blocked using 10% newborn calf se-
rum diluted in PBS for 1 h at room temperature. Cells were incubated 
with primary antibodies (FMNL3 1:600, N-cadherin 1:200) diluted in 
PBS with 1% newborn calf serum for 1 h. Cells were washed, and 
secondary antibodies diluted 1:500 in PBS were added for 1 h. 
TRITC–phalloidin was used at 50 nM. Cells were stained with 0.4 ng/μl 
4′,6-diamidino-2-phenylindole (DAPI) for 10 min before final rinse 
with PBS. Cells were mounted to glass slides using PVA-DABCO. Im-
ages were acquired using a Nikon TE-2000E microscope with either 
the 60×/1.4 numerical aperture (NA) or 4×/0.13 NA objective, a 
Roper CoolSnap camera, and Nikon Elements software.
Wound-healing assays
Cells were plated at high density (310,000 cells on 18-mm cover-
slips in a 12-well plate) and incubated overnight. Coverslips were 
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observation expressed significantly less GFP than the highest-ex-
pressing cells. Therefore, we conclude that the levels of FMNL3-
NC-GFPint in our live-cell experiments were less than the level of 
endogenous FMNL3.
